mesoView CO., LTD.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
mesoView CO., LTD. takes the development of slide-free digital imaging platforms as its primary goal, and offers integrated hardware and software combinations to create advanced medical imaging technology solutions. Main products: MESOscope for academic and research use; PATHOscope for auxiliary medical diagnosis.
The content above was translated by Ai
Founded Year
2022
Unified Business No.
90197314
Status
Active
Number of Employees
0
Total Paid-in
Capital
17,584,875 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
mesoView develops PATHOscope, a next-generation digital pathology platform that delivers rapid, non-destructive intraoperative tissue assessment to support surgical decision-making, reduce repeat surgeries, and improve patient outcomes. The company holds multiple patents, has completed multi-center clinical validations in Taiwan and the U.S., and partners with leading medical centers. The team combines expertise in optoelectronics, AI, and clinical pathology to advance precision surgical diagnostics.
The content above was translated by Ai
